Preparing your space
Your library and workspace are being arranged now.
Preparing your space
Your library and workspace are being arranged now.
Something material has happened since this was last valued, 1 week ago. The number below still stands on the last filed facts; it sorts below unflagged companies on the screen until the next filing, or until somebody confirms the thesis holds.
Loading the business overview…
Explore the research to see how business evidence informs assumptions and valuation.
Start with the business evidence, then follow the assumptions through to scenarios and valuation.
Valuation and assumptionslululemon is a turnaround - a high-quality, debt-free, direct-to-consumer premium apparel business whose brand has lost relevance in its home market - whose economics are primarily driven by Americas comparable sales, normalized operating margin, and the durability of international growth. Its principal competitive advantage is a brand that historically supported a 60% gross margin and a 32% return on equity without conventional advertising, though that advantage is now narrow and demonstrably eroding, with Alo Yoga and Vuori proving the position is replicable. Its most important vulnerabilities are that women's leggings, the founding category, fell roughly 20% year-over-year amid a state investigation into product claims, that Americas comparable sales fell 12% against international down only 3%, and that an 825-store estate creates fixed-cost operating leverage that works violently in reverse. Under the base case, revenue troughing near $9.6 billion in fiscal 2028 before recovering to $12.1 billion by fiscal 2035, with operating margin recovering from a 12% trough to 15% - five points below the six-year historical average and well below the 23.7% peak - implies intrinsic value of approximately $135 per share versus a market price of $99.25. The investment therefore depends primarily on whether the brand damage is cyclical or structural, a question with no reliable base rate, though the downside is unusually well bounded: the company has zero debt, roughly $1.5 billion of net cash, positive free cash flow in every scenario, and trades below its zero-growth earnings power value of $109. The most important evidence to monitor is Americas comparable sales, women's leggings revenue, gross margin excluding tariff refunds, inventory units against sales, and whether the company begins discounting in North America.
| Field | Value |
|---|---|
| Company | lululemon athletica inc. |
| Ticker / exchange | LULU / NASDAQ |
| Current share price | $99.25 (after-hours, 2026-09-03) [S8]; last regular close $121.77 [S3][S6] |
| Market capitalization | ~$11.5bn [Est., 115.5M diluted shares [V] × $99.25] |
| Enterprise value | ~$10.0bn [Est., net cash ~$1.5bn] |
| Industry | Premium athletic and technical apparel, direct-to-consumer retail |
| Primary geographies | Americas (dominant), Greater China, rest of world |
| Investment classification | Turnaround |
| Business quality | Medium-to-High |
| Competitive advantage | Weak-to-Moderate (deteriorating) |
| Financial quality | Strong |
| Growth outlook | Weak |
| Balance-sheet risk | Low |
| Valuation attractiveness | Attractive |
| Overall risk | High |
| Base-case intrinsic value | $135 |
| Bull-case intrinsic value | $230 |
| Bear-case intrinsic value | $65 |
| Probability-weighted value | $134.25 [Est.] |
| Upside/downside vs price | +35.3% |
| Expected annualized return, base case (3–5yr) | +12% to +19% [Est.] |
| Investment stance | Buy |
Two things about that stance need saying immediately. First, it rests on a price that is an after-hours quote hours old, and on a business whose trajectory is currently deteriorating rather than stabilising. Second, 34 analysts rate the stock "Hold" with an average target of $127.35 [S11] — for once I am more positive than the street, which is the reverse of my position on most of the US names in this series.
Why it may be attractive. The valuation has collapsed faster than the earnings. The shares are down roughly 42% year-to-date and 71% over five years [S11], trading at an eight-year low below $100 [S10], against a business that still generated a 60.5% gross margin and an 18.8% operating margin in the quarter just reported [S1] with zero short-term debt [V] and roughly $1.5bn of net cash. On the cut full-year guidance of $9.48–9.73 of EPS [S1][S3], the stock is at roughly 10.3× earnings and about 4.8× EV/EBITDA [Est.].
What the market may be misunderstanding. The market is extrapolating an Americas collapse across the whole company. Americas comparable sales fell 12%; international comparable sales fell 3% [S1]. Roughly a third of this business is not broken. Separately, the reported EPS beat of $2.92 against a $1.79 consensus [S10] included $0.86 from tariff refunds [S1] — and $105m of further refunds have deliberately been excluded from guidance [S4], so the guidance is conservative in one specific, quantified way.
The most important value driver. Americas comparable sales. At −12% [S1] this is the entire problem, and a sustained five-point change in the Americas trajectory is worth roughly $45 per share [Est., §17].
The largest risk. That the brand damage is structural rather than cyclical. Women's leggings — the founding product — fell roughly 20% year-over-year [S6], amid a Texas state investigation into claims about "forever chemicals" (PFAS) in the leggings [S6] and a proxy contest involving the founder [S6]. Premium apparel brands that lose cultural relevance often do not recover.
What must be true. That Americas comps trough within the next two to three quarters rather than continuing to deteriorate; that operating margin stabilises in the mid-teens rather than continuing toward ten; and that incoming CEO Heidi O'Neill, a Nike veteran who takes over next week [S7], can restore product relevance. All three, not one.
Two years ago I would have rated this Moderate or Wide. The evidence no longer supports it, and the honest thing is to say what changed rather than to defend a prior rating.
825 company-operated stores [S2] with no wholesale dependency gives full margin capture, direct customer data and pricing control. It also removes any buffer — a wholesale-led brand can push inventory to partners in a bad season; lululemon cannot.
Real design and materials capability, but not patent-protected in any durable way. The PFAS investigation [S6] shows that the technical claim can become a liability rather than an advantage.
At $10.4bn of revenue, lululemon has purchasing scale over a fragmented manufacturing base, but far less than Nike.
A consumer buys a different pair of leggings. There is nothing else to say.
| Test | Result |
|---|---|
| ROIC above WACC | Yes, comfortably — see §11 |
| Stable or rising market share | No — declining. Americas comps −12% [S1] |
| Pricing power | Present but eroding. Underlying gross margin fell ~360bps ex-refunds [Est. from S1] |
| Gross margin | 60.5% [S1] — still exceptional |
| ROE | 32.0% [S9] |
| Retention / churn | Not disclosed [Unverified] |
| Incremental margin | Deeply negative — FY2024→FY2025 revenue +$510M produced operating income −$300M [V, computed] |
The last row is the one that decides the rating. A business whose revenue grew $510M while operating income fell $300M has, in that period, no pricing power and no operating leverage. That is a narrow moat by any consistent standard, however good the gross margin looks.
| Risk | Type | Prob. | Financial impact | Horizon | Leading indicator | Mitigating factors | Priced in? |
|---|---|---|---|---|---|---|---|
| Brand damage proves structural | Business | 40% | −$50 to −$70/share | 2–6yr | Women's leggings revenue; Americas comps | New CEO; international strength; men's | Partially — this is most of the 42% YTD decline |
| Americas comps keep deteriorating | Business | 45% | −$35 to −$50/share | 1–3yr | Quarterly comps; Q3 guided −10% to −11% | Easier comparisons from FY2027 | Partially |
| Margin compresses below 12% | Business | 35% | −$30 to −$40/share | 1–3yr | Gross margin ex-tariff; SG&A deleverage | Zero debt; cost discipline; inventory units down | Partially |
| Promotional environment spreads to North America | Business | 40% | −$25/share | 1–2yr | Competitor discounting; Australia read-through | Choosing not to discount [S6] | No |
| Third consecutive guidance cut | Execution | 45% | −$15/share, temporary | 0–6 months | Q3 results | Guidance already reset hard | Partially |
| PFAS investigation escalates or spreads | Legal / reputational | 30% | −$15 to −$30/share | 1–3yr | Texas docket; other state actions | Company says PFAS phased out by early 2024 [S6] | No |
| Store estate becomes a fixed-cost trap | Financial | 30% | −$15/share | 2–5yr | Store count; sales per store; lease disclosures | Capex already below D&A [V] | No |
| Founder proxy contest escalates | Governance | 25% | −$8/share, distraction | 0–2yr | Filings | Company has distanced itself [S6] | Partially |
| Buybacks continue above intrinsic value | Capital allocation | 25% | −$8/share | 1–3yr | Share count and average price | Stock now below my base case | No |
| Balance-sheet distress | Financial | <2% | Immaterial | — | — | Zero debt, $1.5bn cash [V] | Yes |
Distinguishing the three types is unusually clarifying here. Business risk is high and concentrated in one question. Financial risk is close to zero — no debt, positive free cash flow, falling share count. Valuation risk is negative: at roughly 10× guided earnings and 4.8× EV/EBITDA [Est.], the multiple is a cushion rather than a hazard.
| Assumption | Value | Basis |
|---|---|---|
| Risk-free rate | 4.3% | [Unverified] |
| Beta | 0.90 | [S9] — reported, and lululemon's long trading history makes this reasonably meaningful |
| Equity risk premium | 5.0% | [Est.] |
| Cost of equity | 8.8% | Derived |
| Execution / brand-risk premium | +0.7 points | [Est.] — added for a brand in demonstrable decline with an unresolved product-claims investigation |
| WACC | 9.5% | Derived. No debt, so WACC equals adjusted cost of equity [V] |
| Terminal growth | 2.5% | [Est.] — mature apparel, below nominal GDP |
| Tax rate | 30% | [Est., Unverified] — lululemon's effective rate has run around 30% |
| Diluted share count | 115.5M | [V], three months to 2026-05-03 |
| Share count assumption | Held flat despite an 11.8% reduction over the verified period [V] | Deliberately conservative |
| Stock-based compensation | Fully expensed. Not stored; estimated at $120–140M a year [Est.] and already deducted from the verified operating income [V] used here. | Deliberate |
| Operating leases | Not capitalised as debt — magnitude [Unverified] | Flagged as a gap |
Two treatment notes. I have not added lease liabilities to net debt, because I could not size them; doing so would reduce the valuation, and for an 825-store retailer the effect could be meaningful. And I use the $99.25 after-hours quote [S8] rather than the $121.77 regular close [S3] — at the close price every upside figure in this report would be roughly 22 percentage points lower.
Growth vs reinvestment vs incremental ROIC — consistent, and the direction is unusual. I forecast revenue troughing then growing 3–4% while assuming capex stays near depreciation. That is not a claim of rising returns; it is a claim that lululemon stops opening stores into negative comps. The verified Q1 data already shows capex below D&A [V], so the assumption has support. Note the inversion: in this model, less reinvestment is a positive, because incremental ROIC was negative in FY2025 (§11).
Pricing vs volume vs market share — consistent and deliberately unfavourable. I assume lululemon holds price and loses volume — exactly what it is doing in Australia [S6]. I do not assume both price and volume recover. A forecast that has comps recovering while gross margin returns to 60%+ ex-tariffs is assuming two favourable outcomes with no mechanism connecting them.
Margins vs competitive intensity — this is where my forecast is most strained. I assume normalized operating margin of 15% while simultaneously accepting that the competitive set is permanently larger and that management is increasing marketing investments [S1]. Those pull against each other. My defence is that 15% is already 5 points below the six-year average [Est. from V] and 8.7 points below the FY2024 peak. But if the promotional environment spreads from Australia to North America, 12–13% is the right number and my base case is roughly 20% too high.
Capex vs depreciation vs free cash flow — consistent and verifiable. Capex of $127.4M against D&A of $135.3M in Q1 [V] means there is no deferred cost landing in a future P&L. This is the cleanest capex relationship of any company in this series apart from Palantir.
Terminal growth vs terminal reinvestment vs terminal ROIC — consistent. 2.5% terminal growth with capex roughly equal to depreciation implies a high terminal ROIC, which lululemon comfortably earns even in a bad year (§11).
All figures $bn, fiscal years ending late January or early February.
| Year | Revenue | Op. margin | EBIT | NOPAT (30%) | D&A | Capex | FCF | PV @9.5% |
|---|---|---|---|---|---|---|---|---|
| FY2026E | 10.425 | 14.7% | 1.53 | 1.071 | 0.55 | 0.60 | 1.021 | 0.933 |
| FY2027E | 9.80 | 12.0% | 1.176 | 0.823 | 0.57 | 0.54 | 0.853 | 0.711 |
| FY2028E | 9.60 | 12.0% | 1.152 | 0.806 | 0.57 | 0.54 | 0.836 | 0.637 |
| FY2029E | 9.90 | 13.0% | 1.287 | 0.901 | 0.58 | 0.55 | 0.931 | 0.647 |
| FY2030E | 10.30 | 14.0% | 1.442 | 1.009 | 0.59 | 0.56 | 1.039 | 0.660 |
| FY2031E | 10.70 | 14.5% | 1.552 | 1.086 | 0.60 | 0.57 | 1.116 | 0.647 |
| FY2032E | 11.10 | 15.0% | 1.665 | 1.166 | 0.61 | 0.58 | 1.196 | 0.634 |
| FY2033E | 11.50 | 15.0% | 1.725 | 1.208 | 0.62 | 0.59 | 1.238 | 0.599 |
| FY2034E | 11.80 | 15.0% | 1.770 | 1.239 | 0.63 | 0.60 | 1.269 | 0.561 |
| FY2035E | 12.10 | 15.0% | 1.815 | 1.271 | 0.64 | 0.61 | 1.301 | 0.525 |
Base case ≈ $135.
Terminal value is 54% of enterprise value — the lowest proportion of any company in this series, because the explicit period generates real cash from year one. That is a structurally more reliable valuation than the AI-infrastructure names.
Note the forecast does not credit the buyback. Share count is held flat despite an 11.8% reduction over the verified period [V]. At $99.25 against a $135 base case, continued repurchase is accretive and adds roughly $12–15 per share over five years [Est.] that is not in the $135.
Detailed in §22. The current price implies a normalized operating margin of roughly 11% — below every year in the verified six-year record [V, computed] — or permanent revenue of about $9.0bn.
| Multiple | LULU @ $99.25 | Comment |
|---|---|---|
| P/E on FY2026E guidance midpoint ($9.60) | 10.3× [Est.] | The headline figure |
| P/E excluding the $0.86 tariff benefit ($8.74) | 11.4× [Est.] | The cleaner figure |
| P/E (TTM) | 8.0× [Est. from S9's $12.38 TTM EPS] | Backward-looking, on a declining base |
| EV / FY2026E EBITDA (~$2.08bn) | ~4.8× [Est.] | |
| EV / FY2026E revenue | ~0.96× [Est.] | |
| Price / FCF (FY2026E ~$700M) | ~16× [Est.] | |
| FCF yield | ~6.1% [Est.] | Against a 4.3% risk-free rate |
| Gross margin (TTM) | 55.7% [S9] | Still exceptional for apparel |
| ROE (TTM) | 32.0% [S9] | |
| Dividend yield | None [S9] |
A 6.1% free cash flow yield and 4.8× EV/EBITDA on a debt-free business with a 60% gross margin and 32% ROE is a genuinely low valuation, whatever is wrong with the demand.
Should lululemon trade at a discount? Yes, to its own history, decisively — comps are negative, the brand is impaired, and the margin peak is not returning. Whether it should trade at 4.8× EBITDA, a level normally reserved for structurally declining businesses, is the question, and my answer is no.
Earnings power value (normalized owner earnings of ~$1.05bn capitalised at 9.5%, no growth, plus $1.5bn net cash): $11.05bn + $1.5bn = $12.55bn = $109 per share.
That figure deserves emphasis: with zero growth assumed forever, lululemon is worth roughly $109 against a price of $99.25. So less than zero percent of the current price is growth — the market is paying below the no-growth value. In this series the equivalent figures ranged from 18% (Alibaba) to 94% (Palantir).
Replacement value / liquidation. 825 stores [S2], $1.7bn of inventory [S2], $1.5bn of cash [V], and $4.83bn of book equity [V]. Book value per share is roughly $42 [Est.], so the stock trades at 2.4× book — not a floor, but the asset backing is real and unencumbered.
Each scenario is a causal chain: trigger → operating mechanism → financial consequence → valuation consequence.
Trigger: The brand damage is structural. Premium activewear consumers have durably moved to Alo Yoga and Vuori, and the PFAS investigation permanently impairs trust with the female customer who is lululemon's core.
Operating mechanism: Leggings continue declining at double digits beyond the 20% already reported [S6], and the weakness spreads from leggings to women's tops and outerwear. Americas comps stay worse than −8% for two more years. The promotional environment that began in Australia [S6] reaches North America, and lululemon is forced to abandon its no-discount posture — sacrificing the 60% gross margin that has been its distinguishing feature. Meanwhile the 825-store estate [S2], sized for a growing brand, becomes a fixed-cost trap: rent and payroll do not scale down with comps, so every point of negative comp costs more margin than the last. Store closures begin, with lease-exit costs. The new CEO resets guidance again in her first or second quarter.
Financial consequence: revenue troughs near $8.5bn and stays there. Operating margin settles at 9–10% — below anything in the verified record [V]. Free cash flow falls to roughly $450M but stays positive, because there is no debt and capex is discretionary.
Valuation consequence: normalized FCF around $500M, WACC 11.0% on a structurally impaired brand, terminal growth 1.5%. Intrinsic value: $65 — a 35% decline from here, and still a solvent, cash-generative business with $1.5bn of net cash.
Trigger: The damage is severe but cyclical and category-specific, and the new CEO stabilises product.
Operating mechanism: Americas comps trough in the next two to three quarters as the comparisons ease and the social-media episode fades, then recover toward flat by FY2028. Leggings do not return to prior levels, but the decline stops and "away from body" bottoms, which already gained traction [S6], plus men's — down only 1% [S6] — carry the mix. International continues growing mid-single digits on comps and high single digits on revenue with store openings, so roughly a third of the company keeps working throughout. Heidi O'Neill's first full product cycle lands in FY2028. Management holds price rather than discounting [S6], so gross margin recovers toward 58–59% ex-tariffs as markdowns normalise, while marketing spend stays elevated [S1] and caps operating margin at 15% rather than the 20.3% historical average. Store openings slow to near zero and capex stays below depreciation [V].
Financial consequence: revenue troughs at $9.6bn in FY2028 and recovers to $12.1bn by FY2035; operating margin recovers from a ~12% trough to 15%; free cash flow stays above $830M throughout and reaches $1.3bn.
Valuation consequence: WACC 9.5%, terminal growth 2.5%. Intrinsic value: $135, excluding $12–15 of buyback accretion not credited.
Trigger: Heidi O'Neill executes a genuine product-led turnaround, and the brand recovers cultural relevance.
Operating mechanism: A Nike-trained product executive brings assortment discipline and a marketing cadence lululemon has never had — the company historically grew on community rather than campaigns, which is why increasing marketing investments [S1] is a new lever rather than a defensive cost. The existing strong franchises called out in Q2 — Scuba, Steady State, Define, ABC, Metal Vent Tech [S6] — are extended, and a credible leggings successor arrives. Americas comps turn positive by FY2028. Because lululemon never discounted through the downturn [S6], the brand's price integrity is intact when demand returns, so the recovery comes at full price rather than through promotion — and gross margin returns above 60%. International compounds at a double-digit rate off a base that never broke, and China resumes roughly 20% growth [S13]. The $105M of outstanding tariffs is recovered [S4]. Store openings resume selectively at positive incremental returns. Buybacks at prices near $100 retire 15%+ of the share count.
Financial consequence: revenue recovers past the FY2025 peak to $13.5bn+ by FY2032 with operating margin returning to 19% — below the 23.7% peak but well above my base case. Free cash flow exceeds $1.9bn.
Valuation consequence: WACC 9.0% as execution risk recedes, terminal growth 3.0%. Intrinsic value: $230 — roughly the level the stock traded at earlier in 2026, and below its all-time high.
| Scenario | Value | Probability | Weighted |
|---|---|---|---|
| Bear | $65 | 0.35 | $22.75 |
| Base | $135 | 0.40 | $54.00 |
| Bull | $230 | 0.25 | $57.50 |
| Total | 1.00 | $134.25 |
These sum to 1.00 and I am satisfied they should. Unlike the SpaceX, IREN and Alibaba records in this series, there is no unvaluable structural branch here — no VIE, no financing cliff, no binary regulatory event. lululemon has zero debt [V], positive free cash flow in every scenario I can construct, and a US-listed common share with ordinary shareholder rights. The three scenarios genuinely span the outcome space, and saying so is more useful than manufacturing a tail.
Versus $99.25, the weighted value implies +35.3%.
Sensitivity of the conclusion: if you believe the bear case is 50% likely rather than 35%, the weighted value falls to about $117 — still 18% above the current price. At a 65% bear probability it falls to $100, roughly the current price. The stance is robust to a substantially more pessimistic brand judgement, which is the most useful thing I can say about it.
A 60.5% gross margin [S1], 32% ROE [S9], zero debt [V], near-zero net reinvestment requirement, and no customer concentration. Marked down from what would have been a 9 two years ago because revenue grew $510M in FY2025 while operating income fell $300M [V] — a business with genuinely negative incremental economics in its most recent full year.
Narrow moat. The brand was the moat and the brand is what is breaking: Americas comps −12%, leggings −20% [S1][S6], with Alo and Vuori demonstrating the position is replicable [S14]. Zero switching costs, no network effects, no regulatory barrier. Still an exceptional gross margin, which is why this is a 5 and not a 3.
Two guidance cuts in two quarters, a revenue miss against a two-month-old guide, and buybacks executed through a period of falling intrinsic value. Offset by precise and honest tariff disclosure [S1], conservative exclusion of the remaining $105M [S4], the correct instinct on capex [V], and a genuinely well-matched CEO hire [S7].
Zero short-term debt at every verified date [V], ~$1.5bn cash, positive free cash flow in every scenario, no dividend obligation, and a falling share count. Marked down only because operating lease obligations are unquantified.
Revenue guided to decline 5–7% [S1]; Q3 guided to −10% to −11% [S14]; six consecutive years of decelerating growth ending in contraction. International and men's are the only bright spots.
10.3× guided earnings, 4.8× EV/EBITDA, 6.1% free cash flow yield [Est.], and a price below the zero-growth earnings power value of $109 [Est.].
Bear −35%, base +36%, bull +132%, with a bear case losing only 3.5% a year and no path to insolvency. The bear probability would need to reach roughly 65% before the weighted value fell to the current price.
1. Is this a good business? Yes, structurally — with a serious current problem. A 60% gross margin, 32% ROE, no debt and minimal capital requirements describe an excellent model. Negative incremental economics in FY2025 [V] describe a brand losing its customer.
2. Stronger or weaker? Weaker, clearly and on every operating measure. Six years of decelerating growth ending in a guided decline; operating margin down from 23.7% to roughly 14.7%; leggings down 20%. The only things stronger are the balance sheet and the share count.
3. Durable competitive advantage? Narrow, and narrowing. The brand was the moat; Alo and Vuori have shown it is replicable; there are no switching costs to fall back on.
4. Three most important drivers? (i) Americas comparable sales; (ii) normalized operating margin; (iii) international growth durability.
5. Three largest risks? (i) Brand damage proving structural rather than cyclical; (ii) the promotional environment spreading from Australia to North America; (iii) the 825-store estate becoming a fixed-cost trap.
6. Most important dependency? Brand desirability. Not a supplier in the ordinary sense, but the input on which the 60% gross margin and everything downstream depends.
7. What is the market pricing in? A normalized operating margin of roughly 11% — below every year in the six-year verified record, including the worst — or permanent revenue near $9.0bn. Permanent impairment, not a cyclical trough.
8. Where could the market be wrong? On assuming margins settle below the historical floor; on reading the tariff-inflated EPS beat rather than the 34% underlying decline; and on treating the refusal to discount [S6] as weakness when it is the thing that makes a premium brand recoverable.
9. Fair intrinsic value? $135 base case; $134.25 probability-weighted; an honest range of $65 to $230.
10. Margin of safety today? Roughly 36% to base case and 35% to the weighted value. More usefully: the stock trades below its zero-growth earnings power value of $109, and each individually punitive assumption in §25 still leaves it at or above today's price.
11. Reasonable annualized return over 3–5 years? +12.9% weighted. Bear −3.5%, base +16.4%, bull +30.1%. Note that almost none of the base-case return comes from earnings growth — it comes from the price-to-value gap closing, which is a less comfortable source.
12. Single development that would most strengthen the thesis? Americas comparable sales improving to better than −6% for two consecutive quarters — direct evidence that the decline has troughed rather than continuing.
13. Single development that would most invalidate it? lululemon beginning to discount in North America. That would signal price integrity has been abandoned, and it is the asset on which the entire recovery case rests.
14. At what price does it become clearly attractive? It already is, at $99.25. I set the threshold at $115 — still 15% below base case — because that is the level below which the margin of safety remains adequate even if my normalized margin assumption is two points too high.
15. What price implies excessive optimism? $230 — the bull case, requiring a full product-led brand recovery and a margin return to 19%.
lululemon is a turnaround — a high-quality, debt-free, direct-to-consumer premium apparel business whose brand has lost relevance in its home market — whose economics are primarily driven by Americas comparable sales, normalized operating margin, and the durability of international growth. Its principal competitive advantage is a brand that historically supported a 60% gross margin and a 32% return on equity without conventional advertising, though that advantage is now narrow and demonstrably eroding, with Alo Yoga and Vuori proving the position is replicable. Its most important vulnerabilities are that women's leggings, the founding category, fell roughly 20% year-over-year amid a state investigation into product claims, that Americas comparable sales fell 12% against international down only 3%, and that an 825-store estate creates fixed-cost operating leverage that works violently in reverse. Under the base case, revenue troughing near $9.6 billion in fiscal 2028 before recovering to $12.1 billion by fiscal 2035, with operating margin recovering from a 12% trough to 15% — five points below the six-year historical average and well below the 23.7% peak — implies intrinsic value of approximately $135 per share versus a market price of $99.25. The investment therefore depends primarily on whether the brand damage is cyclical or structural, a question with no reliable base rate, though the downside is unusually well bounded: the company has zero debt, roughly $1.5 billion of net cash, positive free cash flow in every scenario, and trades below its zero-growth earnings power value of $109. The most important evidence to monitor is Americas comparable sales, women's leggings revenue, gross margin excluding tariff refunds, inventory units against sales, and whether the company begins discounting in North America.
This report should be re-run once the Q2 Form 10-Q is filed — that document contains lease obligations, segment detail and inventory composition, three of the largest gaps above — and again after the Q3 results in early December, which will be the first quarter under Heidi O'Neill and the first genuine test of whether the Americas decline has troughed.
The 15% normalized operating margin is the weakest link and carries the conclusion; 11% instead would take the base case to $88, below the current price, and the justification for 15% is an appeal to a six-year verified history spanning 16.4% to 23.7% that may no longer be the right reference class given a permanently larger competitive set and structurally higher marketing spend. Whether the brand damage is cyclical or structural is the widest uncertainty and has no reliable base rate for premium apparel brand recovery. Operating lease obligations are unquantified because long-term debt is explicitly not stored and the 10-K was not read; for an 825-store retailer these behave like debt and would lower the valuation by an unknown amount. Stock-based compensation and research and development are also not stored; SBC is estimated at $120-140M annually and is already inside the verified operating income used here. Critically, the price used is an after-hours quote from 3 September rather than a close - the last regular close was $121.77, at which every upside figure would be roughly 22 percentage points lower. Q2 fiscal 2026 figures come from the press release rather than a filed 10-Q, which had not been filed at the time of writing. Also unresolved: segment operating income, since geography-level profitability is not disclosed; customer retention and repeat-purchase rates, so the brand assessment rests on category revenue rather than cohort behaviour; the scope and likely outcome of the Texas PFAS investigation; and competitor financials, since Alo Yoga and Vuori are private and Nike and Under Armour filings were not read. Note also that lululemon's fiscal year ends in late January or early February, so fiscal 2026 runs to approximately 31 January 2027.
These model scenarios depend on their inputs. Review the assumptions and supporting evidence alongside the implied values.
earnings multiple v2 · as of 2026-09-12
Sign in for the price chart, where every input traces back to a filing, an adjustable scenario sandbox, and companies that move with LULU.
Create a free account →